{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T19:30:48Z","timestamp":1780083048531,"version":"3.54.0"},"reference-count":24,"publisher":"Elsevier BV","issue":"13","license":[{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/100007834","name":"Natural Science Foundation of Ningbo Municipality","doi-asserted-by":"publisher","award":["2021J018"],"award-info":[{"award-number":["2021J018"]}],"id":[{"id":"10.13039\/100007834","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Heliyon"],"published-print":{"date-parts":[[2024,7]]},"DOI":"10.1016\/j.heliyon.2024.e33935","type":"journal-article","created":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T12:49:35Z","timestamp":1719838175000},"page":"e33935","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Ginsenoside Rg1 inhibits multiple myeloma and overcomes bortezomib resistance through AMPK-mTOR pathway"],"prefix":"10.1016","volume":"10","author":[{"ORCID":"https:\/\/orcid.org\/0009-0009-6097-5401","authenticated-orcid":false,"given":"Li","family":"Lin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dong","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuangyue","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tiantian","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.heliyon.2024.e33935_bib1","article-title":"Multiple myeloma: an overview of management","volume":"13","author":"Bird","year":"2019","journal-title":"Palliat Care Soc Pract"},{"key":"10.1016\/j.heliyon.2024.e33935_bib2","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2023.115875","article-title":"Advances in research on potential inhibitors of multiple myeloma","volume":"262","author":"Tang","year":"2023","journal-title":"Eur. J. Med. Chem."},{"issue":"5","key":"10.1016\/j.heliyon.2024.e33935_bib3","first-page":"1584","article-title":"Research Progress on mechanism of bortezomib resistance in multiple myeloma, zhongguo shi yan xue ye","volume":"31","author":"Wang","year":"2023","journal-title":"Xue Za Zhi"},{"key":"10.1016\/j.heliyon.2024.e33935_bib4","article-title":"Ginsenoside Rg1 as a promising adjuvant agent for enhancing the anti-cancer functions of granulocytes inhibited by noradrenaline","volume":"14","author":"Zhu","year":"2023","journal-title":"Front. Immunol."},{"issue":"3","key":"10.1016\/j.heliyon.2024.e33935_bib5","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/j.jgr.2021.11.004","article-title":"Ginsenoside Rg1 suppresses cancer cell proliferation through perturbing mitotic progression","volume":"46","author":"Hong","year":"2022","journal-title":"J Ginseng Res"},{"issue":"1","key":"10.1016\/j.heliyon.2024.e33935_bib6","doi-asserted-by":"crossref","DOI":"10.1002\/jbt.22945","article-title":"Ginsenoside RG1 augments doxorubicin-induced apoptotic cell death in MDA-MB-231 breast cancer cell lines","volume":"36","author":"Liu","year":"2022","journal-title":"J. Biochem. Mol. Toxicol."},{"issue":"4","key":"10.1016\/j.heliyon.2024.e33935_bib7","first-page":"152","article-title":"Molecular genetic aberrations in the pathogenesis of multiple myeloma, Asian Biomed","volume":"17","author":"Bong","year":"2023","journal-title":"Res Rev News)"},{"issue":"2","key":"10.1016\/j.heliyon.2024.e33935_bib8","doi-asserted-by":"crossref","first-page":"693","DOI":"10.4143\/crt.2022.952","article-title":"Cyclophosphamide, bortezomib, and dexamethasone consolidation in patients with multiple myeloma after stem cell transplantation: the KMM130 study","volume":"55","author":"Jung","year":"2023","journal-title":"Cancer Res Treat"},{"issue":"8","key":"10.1016\/j.heliyon.2024.e33935_bib9","doi-asserted-by":"crossref","DOI":"10.3390\/cancers15082199","article-title":"Euchromatic histone lysine methyltransferase 2 inhibition enhances carfilzomib sensitivity and overcomes drug resistance in multiple myeloma cell lines","volume":"15","author":"Mereu","year":"2023","journal-title":"Cancers"},{"issue":"11","key":"10.1016\/j.heliyon.2024.e33935_bib10","doi-asserted-by":"crossref","DOI":"10.3390\/biom12111647","article-title":"Synergistically anti-multiple myeloma effects: flavonoid, non-flavonoid polyphenols, and bortezomib","volume":"12","author":"Ding","year":"2022","journal-title":"Biomolecules"},{"key":"10.1016\/j.heliyon.2024.e33935_bib11","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2022.216019","article-title":"Luteolin inhibits the TGF-beta signaling pathway to overcome bortezomib resistance in multiple myeloma","volume":"554","author":"Li","year":"2023","journal-title":"Cancer Lett."},{"key":"10.1016\/j.heliyon.2024.e33935_bib12","article-title":"Neosetophomone B induces apoptosis in multiple myeloma cells via targeting of AKT\/SKP2 signaling pathway","author":"Kuttikrishnan","year":"2023","journal-title":"Cell Biol. Int."},{"issue":"6","key":"10.1016\/j.heliyon.2024.e33935_bib13","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1111\/1440-1681.13643","article-title":"Solamargine induces autophagy-mediated apoptosis and enhances bortezomib activity in multiple myeloma","volume":"49","author":"Han","year":"2022","journal-title":"Clin. Exp. Pharmacol. Physiol."},{"issue":"7","key":"10.1016\/j.heliyon.2024.e33935_bib14","doi-asserted-by":"crossref","DOI":"10.3390\/ijms24076019","article-title":"Autophagy: a potential therapeutic target to tackle drug resistance in multiple myeloma","volume":"24","author":"Bashiri","year":"2023","journal-title":"Int. J. Mol. Sci."},{"issue":"7","key":"10.1016\/j.heliyon.2024.e33935_bib15","doi-asserted-by":"crossref","first-page":"3009","DOI":"10.1002\/ptr.7796","article-title":"Total steroidal saponins from black nightshade (Solanum nigrum L.) overcome tumor multidrug resistance by inducing autophagy-mediated cell death in vivo and in vitro","volume":"37","author":"Wang","year":"2023","journal-title":"Phytother Res."},{"issue":"1","key":"10.1016\/j.heliyon.2024.e33935_bib16","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/s12943-020-1138-4","article-title":"Autophagy and autophagy-related proteins in cancer","volume":"19","author":"Li","year":"2020","journal-title":"Mol. Cancer"},{"issue":"19","key":"10.1016\/j.heliyon.2024.e33935_bib17","doi-asserted-by":"crossref","first-page":"10407","DOI":"10.18632\/aging.205085","article-title":"PLCL1 suppresses tumour progression by regulating AMPK\/mTOR-mediated autophagy in renal cell carcinoma","volume":"15","author":"Pan","year":"2023","journal-title":"Aging (Albany NY)"},{"key":"10.1016\/j.heliyon.2024.e33935_bib18","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.semcancer.2019.07.003","article-title":"mTOR: role in cancer, metastasis and drug resistance","volume":"59","author":"Murugan","year":"2019","journal-title":"Semin. Cancer Biol."},{"issue":"1","key":"10.1016\/j.heliyon.2024.e33935_bib19","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1186\/s12906-023-04142-1","article-title":"Hepatocellular Carcinoma cells: activity of Amygdalin and Sorafenib in Targeting AMPK\/mTOR and BCL-2 for anti-angiogenesis and apoptosis cell death","volume":"23","author":"El-Sewedy","year":"2023","journal-title":"BMC Complement Med Ther"},{"issue":"5","key":"10.1016\/j.heliyon.2024.e33935_bib20","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1038\/s41568-021-00344-2","article-title":"Autophagy in tumour immunity and therapy","volume":"21","author":"Xia","year":"2021","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.heliyon.2024.e33935_bib21","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijbiomac.2023.125453","article-title":"New fungal protein from Pleurotus ferulae lanzi induces AMPK-mediated autophagy and G1-phase cell cycle arrest in A549 lung cancer cells","volume":"244","author":"Liu","year":"2023","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.heliyon.2024.e33935_bib22","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2023.1149191","article-title":"Amino acid modified OCMC-g-Suc-beta-CD nanohydrogels carrying lapatinib and ginsenoside Rg1 exhibit high anticancer activity in a zebrafish model","volume":"14","author":"Cui","year":"2023","journal-title":"Front. Pharmacol."},{"issue":"5","key":"10.1016\/j.heliyon.2024.e33935_bib23","first-page":"2056","volume":"24","author":"Li","year":"2019","journal-title":"J BUON"},{"key":"10.1016\/j.heliyon.2024.e33935_bib24","doi-asserted-by":"crossref","DOI":"10.1155\/2020\/8886955","article-title":"Ginsenoside Rg1 induces apoptotic cell death in triple-negative breast cancer cell lines and prevents carcinogen-induced breast tumorigenesis in sprague dawley rats","volume":"2020","author":"Chu","year":"2020","journal-title":"Evid Based Complement Alternat Med"}],"container-title":["Heliyon"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405844024099663?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405844024099663?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T23:00:32Z","timestamp":1778886032000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2405844024099663"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7]]},"references-count":24,"journal-issue":{"issue":"13","published-print":{"date-parts":[[2024,7]]}},"alternative-id":["S2405844024099663"],"URL":"https:\/\/doi.org\/10.1016\/j.heliyon.2024.e33935","relation":{},"ISSN":["2405-8440"],"issn-type":[{"value":"2405-8440","type":"print"}],"subject":[],"published":{"date-parts":[[2024,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Ginsenoside Rg1 inhibits multiple myeloma and overcomes bortezomib resistance through AMPK-mTOR pathway","name":"articletitle","label":"Article Title"},{"value":"Heliyon","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.heliyon.2024.e33935","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"e33935"}}